Tender Results of Aok Plus Die Gesundheitskasse Fur Sachsen Und Thuringen

Aok Plus Die Gesundheitskasse Fur Sachsen Und Thuringen Tender Result

Result Stage: Awarded  (AOC Available)
Germany
Contract Date6 Sep 2019
Contract AmountRefer Documents 
Non-exclusive drug discount agreements according to § 130a para. 8 SGB V with any final option for the active ingredient combination Valsartan/Amlodipine (ATC code according to WHO: C09DB01)

Aok Plus Die Gesundheitskasse Fur Sachsen Und Thuringen Tender Result

Result Stage: Awarded  (AOC Available)
Germany
Contract Date16 Aug 2019
Contract AmountRefer Documents 
Non-exclusive drug discount agreements according to § 130a para. 8 SGB V with any final option to the active ingredient Gefitinib (ATC code according to WHO: L01XE02)

Aok Plus Die Gesundheitskasse Fur Sachsen Und Thuringen Tender Result

Result Stage: Awarded  (AOC Available)
Germany
Contract Date16 Aug 2019
Contract AmountRefer Documents 
Non-exclusive drug discount agreements according to § 130a para. 8 SGB V with any final option to the active ingredient Solifenacin (ATC code according to WHO: G04BD08)

Aok Plus Die Gesundheitskasse Fur Sachsen Und Thuringen Tender Result

Result Stage: Awarded  (AOC Available)
Germany
Contract Date24 Jul 2019
Contract AmountRefer Documents 
Non-exclusive drug discount agreements according to § 130a para. 8 SGB V with any final option to the active substance Interferon beta-1a (ATC code according to WHO: L03AB07)

Aok Plus Die Gesundheitskasse Fur Sachsen Und Thuringen Tender Result

Result Stage: Awarded  (AOC Available)
Germany
Contract Date10 Jul 2019
Contract AmountRefer Documents 
Non-exclusive drug discount agreements according to § 130a para. 8 SGB V with any final option to the active ingredient Atomoxetin (ATC code according to WHO: N06BA09)

Aok Plus Die Gesundheitskasse Fur Sachsen Und Thuringen Tender Result

Result Stage: Awarded  (AOC Available)
Germany
Contract Date10 Jul 2019
Contract AmountRefer Documents 
Non-exclusive drug discount agreements according to § 130a para. 8 SGB W with any final option to the active ingredient Granisetron (ATC code according to WHO: A04AA02)

Aok Plus Die Gesundheitskasse Fur Sachsen Und Thuringen Tender Result

Result Stage: Awarded  (AOC Available)
Germany
Contract Date10 Jul 2019
Contract AmountRefer Documents 
Non-exclusive drug discount agreements according to § 130a para. 8 SGB V with any final option to the active ingredient Pegfilgrastim (ATC code according to WHO: L03AA13)

Aok Plus Die Gesundheitskasse Fur Sachsen Und Thuringen Tender Result

Result Stage: Awarded  (AOC Available)
Germany
Contract Date10 Jul 2019
Contract AmountRefer Documents 
Non-exclusive drug discount agreements according to § 130a para. 8 SGB V with any final option to the active ingredient Aprepitant (ATC code according to WHO: A04AD12), for oral administration

Aok Plus Die Gesundheitskasse Fur Sachsen Und Thuringen Tender Result

Result Stage: Awarded  (AOC Available)
Germany
Contract Date10 Jul 2019
Contract AmountRefer Documents 
Non-exclusive drug discount agreements according to § 130a para. 8 SGB V with any final option to the active ingredient Filgrastim (ATC code by WHO: L03AA02)

Aok Plus Die Gesundheitskasse Fur Sachsen Und Thuringen Tender Result

Result Stage: Awarded  (AOC Available)
Germany
Contract Date10 Jul 2019
Contract AmountRefer Documents 
Non-exclusive drug discount agreements according to § 130a para. 8 SGB V with any final option to the active ingredient Lipegfilgrastim (ATC code according to WHO: L03AA14)
71-80 of 209 active Tender Results